{"id":23307,"date":"2026-08-21T17:28:35","date_gmt":"2026-08-21T15:28:35","guid":{"rendered":"https:\/\/aminogram.com\/?p=23307"},"modified":"2026-08-21T17:35:44","modified_gmt":"2026-08-21T15:35:44","slug":"bioelectrical-impedance-analysis-clinical-practice-guidelines","status":"publish","type":"post","link":"https:\/\/aminogram.com\/en\/bioelectrical-impedance-analysis-clinical-practice-guidelines\/","title":{"rendered":"Bioelectrical Impedance Analysis: A tool recommended by national and international clinical practice guidelines"},"content":{"rendered":"

Over the past two decades, bioelectrical impedance analysis (BIA) has become a mature technology, supported by abundant scientific literature and integrated into numerous clinical practice guidelines.
\nBy standardizing its modalities of use, these recommendations strengthen its scientific legitimacy, harmonize clinical practices, and promote its adoption in the assessment of body composition.<\/p>\n

\n

The first recognitions of BIA in clinical practice guidelines<\/h2>\n

Between 2002 and 2004, ESPEN (European Society for Clinical Nutrition and Metabolism), the leading European scientific society in clinical nutrition, brought together an international working group composed of BIA experts, including several authors of reference equations and methods, notably Kyle, Deurenberg, Elia, Scharfetter, and Pichard. The objective was to critically evaluate the available scientific data in order to establish the physical foundations of the method, to specify its performance, clinical indications, limitations, and the conditions necessary for its standardized use. This work led to the publication, in 2004 in Clinical Nutrition, of two complementary articles: Bioelectrical impedance analysis \u2013 Part I: Review of Principles and Methods1<\/a><\/sup> and Part II: Utilization in Clinical Practice2<\/a><\/sup>. These two publications remain today foundational references for the standardization of BIA.<\/p>\n<\/section>\n

\n

Current guidelines recommending the use of BIA in clinical practice<\/h2>\n

BIA is mainly integrated into recommendations and diagnostic algorithms in the context of malnutrition and obesity.<\/p>\n

The field of clinical nutrition has gradually structured around several international reference scientific societies, including ESPEN, ASPEN (American Society for Parenteral and Enteral Nutrition), FELANPE (Federaci\u00f3n Latinoamericana de Terapia Nutricional, Nutrici\u00f3n Cl\u00ednica y Metabolismo), and PENSA (Parenteral and Enteral Nutrition Society of Asia). In a collaborative international effort among these four major scientific societies, the Global Leadership Initiative on Malnutrition (GLIM) was created in 2016 to harmonize the diagnosis of malnutrition in adults on an international scale.<\/p>\n

The GLIM criteria3<\/a><\/sup>, first published in 2019, standardized the diagnosis of malnutrition. BIA was recognized as a method for assessing muscle mass, notably through two indicators, the Fat-Free Mass Index (FFMI) and the Appendicular Skeletal Muscle Index (ASMI). Subsequent publications in 20224<\/a><\/sup> and 20255<\/a><\/sup> have maintained BIA among the usable methods for evaluating the muscle mass criterion. These recommendations, published in two reference journals in clinical nutrition, Clinical Nutrition and JPEN (Journal of Parenteral and Enteral Nutrition), demonstrate the recognition of this method by the main international clinical nutrition communities.<\/p>\n

In addition to these international initiatives, ESPEN has published several clinical practice guidelines over the years supporting the use of BIA. In 2015, in the context of diagnosing malnutrition, ESPEN specifically mentioned the FFMI6<\/a><\/sup>. In 2017, in its publication dedicated to definitions and terminology in clinical nutrition7<\/a><\/sup>, BIA was recommended for the assessment of malnutrition, sarcopenia, and sarcopenic obesity, as well as for monitoring patients during their nutritional management and treatment. These recommendations were subject to a high consensus, with 97% agreement. That same year, for cancer patients, ESPEN formulated specific recommendations in favor of an objective and quantitative assessment of muscle mass8<\/a><\/sup>.<\/p>\n

In 2022, ESPEN and the European Association for the Study of Obesity (EASO) established a consensus on the diagnosis of sarcopenic obesity (SO), defined by the coexistence of excess adiposity and decreased muscle mass and function. The diagnosis notably integrates fat mass (%FM) and skeletal muscle mass adjusted for weight (SMM\/W), which can be evaluated by BIA9<\/a><\/sup>.<\/p>\n

ASPEN’s position regarding BIA has gradually shifted towards recognizing its value in clinical practice. In 2019, a systematic review10<\/a><\/sup> did not yet allow for the recommendation of its systematic use, mainly due to the heterogeneity of devices and proprietary equations, as well as their limited validation in different populations. Since then, the evolution of available data has led to a more favorable place for BIA in international guidelines. In the GLIM guidelines published in 20224<\/a><\/sup>, BIA is explicitly recognized as a method to assess or estimate skeletal muscle mass. This evolution highlights the growing integration of BIA in the assessment of muscle mass and malnutrition, while maintaining the need for standardization of methods and interpretation adapted to the clinical context.<\/p>\n

Nutritional assessment by BIA has also been studied in various pathologies. In 2014, the ERS (European Respiratory Society) recommended its use, notably through FFMI, SMMI (Skeletal Muscle Mass Index), ASMI, and fat mass (FM), for the nutritional and prognostic assessment of patients with chronic obstructive pulmonary disease (COPD)11<\/a><\/sup>. Similarly, the AND (Academy of Nutrition and Dietetics) guidelines concerning cystic fibrosis12<\/a><\/sup> and HIV infection13<\/a><\/sup> include BIA among the nutritional assessment methods.<\/p>\n

In Asia, there is a growing interest in the use of BIA in critically ill patients, as evidenced by a Chinese clinical practice guideline on nutritional assessment and monitoring14<\/a><\/sup>, which recommends the use of BIA for nutritional risk screening and skeletal muscle mass monitoring, as well as a Korean single-center observational study15<\/a><\/sup> on the utility of phase angle and the ECW\/TBW ratio for nutritional assessment and prognosis prediction in intensive care patients.<\/p>\n<\/section>\n

\n

Expert recommendations for BIA applications in research and clinical practice<\/h2>\n

The series of publications initiated in 2025 by Prado, Heymsfield, Gonzalez, and Norman16<\/a>,17<\/a><\/sup>, bringing together nearly 30 international experts in body composition, highlights the complementarity between expert groups and scientific societies. It aims to address a recurring problem: the terminological and methodological confusion surrounding body composition assessment. It returns to the methodological foundations of the discipline by defining the different levels of body organization, harmonizing terminology, and specifying, for each measurement method\u2014bioimpedance, DXA, CT, and ultrasound\u2014its principles, validity, reliability, and limitations. This series also reflects the evolutions in the field over the past twenty years since the 2004 ESPEN guidelines1<\/a>,2<\/a><\/sup>, notably by clearly distinguishing BIA (SF\/MF) from BIS and addressing the limitations related to devices whose proprietary algorithms for data processing and interpretation are not fully transparent.<\/p>\n<\/section>\n

\n

The place of BIA in French guidelines<\/h2>\n

BIA is part of current French guidelines, both for the diagnosis of malnutrition and the assessment of sarcopenic obesity. The HAS (French National Authority for Health), in collaboration with the French Federation of Nutrition (FFN), has published several good practice guidelines integrating the use of BIA: for malnutrition in people aged 70 and over in 202118<\/a><\/sup>, in adults under 70 in 201919<\/a><\/sup>, and in adult obesity in 202220<\/a><\/sup>. Parameters such as FM%, SMM\/W, FFMI, and ASMI are included in the HAS guidelines.<\/p>\n<\/section>\n

\n

In summary<\/h2>\n

The integration of BIA into the recommendations of scientific societies and reference organizations represents a major step forward for this technology. Its inclusion in the guidelines helps to strengthen its clinical legitimacy, harmonize practices, and promote its adoption by healthcare professionals.<\/p>\n

Find all these recommendations in our summary table of
\nInternational Clinical Practice Guidelines<\/a>
\nmentioning the use of BIA.<\/p>\n<\/section>\n

\n

References<\/h2>\n
    \n
  1. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, G\u00f3mez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C; Composition of the ESPEN Working Group. Bioelectrical impedance analysis–part I: review of principles and methods. Clin Nutr. 2004 Oct;23(5):1226-43.
    \n    doi: 10.1016\/j.clnu.2004.06.004<\/a>.
    \n    PMID: 15380917<\/a>.<\/li>\n
  2. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel G\u00f3mez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, M W J Schols A, Pichard C; ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004 Dec;23(6):1430-53.
    \n    doi: 10.1016\/j.clnu.2004.09.012<\/a>.
    \n    PMID: 15556267<\/a>.<\/li>\n
  3. Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats A, Crivelli A, Evans DC, Gramlich L, Fuchs-Tarlovsky V, Keller H, Llido L, Malone A, Mogensen KM, Morley JE, Muscaritoli M, Nyulasi I, Pirlich M, Pisprasert V, de van der Schueren MAE, Siltharm S, Singer P, Tappenden K, Velasco N, Waitzberg D, Yamwong P, Yu J, Van Gossum A, Compher C; GLIM Core Leadership Committee; GLIM Working Group. GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Clin Nutr. 2019 Feb;38(1):1-9.
    \n    doi: 10.1016\/j.clnu.2018.08.002<\/a>.
    \nEpub 2018 Sep 3.
    \n    PMID: 30181091<\/a>.<\/li>\n
  4. Compher C, Cederholm T, Correia MITD, Gonzalez MC, Higashiguch T, Shi HP, Bischoff SC, Boirie Y, Carrasco F, Cruz-Jentoft A, Fuchs-Tarlovsky V, Fukushima R, Heymsfield SB, Mourtzakis M, Muscaritoli M, Norman K, Nyulasi I, Pisprasert V, Prado CM, de van der Schuren M, Yoshida S, Yu J, Jensen G, Barazzoni R. Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition diagnosis of malnutrition. JPEN J Parenter Enteral Nutr. 2022 Aug;46(6):1232-1242.
    \n    doi: 10.1002\/jpen.2366<\/a>.
    \nEpub 2022 Apr 19.
    \n    PMID: 35437785<\/a>.<\/li>\n
  5. Jensen GL, Cederholm T, Correia MITD, Gonzalez MC, Fukushima R, Pisprasert V, Blaauw R, Braz DC, Carrasco F, Cruz Jentoft AJ, Cuerda C, Evans DC, Fuchs-Tarlovsky V, Gramlich L, Shi HP, Hasse JM, Hiesmayr M, Hiki N, Jager-Wittenaar H, Jahit S, J\u00e1quez A, Keller H, Klek S, Malone A, Mogensen KM, Mori N, Mundi M, Muscaritoli M, Ng D, Nyulasi I, Pirlich M, Schneider S, de van der Schueren M, Siltharm S, Singer P, Steiber A, Tappenden KA, Yu J, van Gossum A, Wang JY, Winkler MF, Compher C, Barazzoni R. GLIM consensus approach to diagnosis of malnutrition: A 5-year update. JPEN J Parenter Enteral Nutr. 2025 May;49(4):414-427.
    \n    doi: 10.1002\/jpen.2756<\/a>.
    \nEpub 2025 Apr 14.
    \n    PMID: 40223699<\/a>; PMCID: PMC12053077.<\/li>\n
  6. Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, de van der Schueren MA, Singer P. Diagnostic criteria for malnutrition – An ESPEN Consensus Statement. Clin Nutr. 2015 Jun;34(3):335-40.
    \n    doi: 10.1016\/j.clnu.2015.03.001<\/a>.
    \nEpub 2015 Mar 9.
    \n    PMID: 25799486<\/a>.<\/li>\n
  7. Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, Compher C, Correia I, Higashiguchi T, Holst M, Jensen GL, Malone A, Muscaritoli M, Nyulasi I, Pirlich M, Rothenberg E, Schindler K, Schneider SM, de van der Schueren MA, Sieber C, Valentini L, Yu JC, Van Gossum A, Singer P. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017 Feb;36(1):49-64.
    \n    doi: 10.1016\/j.clnu.2016.09.004<\/a>.
    \nEpub 2016 Sep 14.
    \n    PMID: 27642056<\/a>.<\/li>\n
  8. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, H\u00fctterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, M\u00fchlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11-48.
    \n    doi: 10.1016\/j.clnu.2016.07.015<\/a>.
    \nEpub 2016 Aug 6.
    \n    PMID: 27637832<\/a>.<\/li>\n
  9. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, Frara S, Fr\u00fchbeck G, Genton L, Gepner Y, Giustina A, Gonzalez MC, Han HS, Heymsfield SB, Higashiguchi T, Laviano A, Lenzi A, Nyulasi I, Parrinello E, Poggiogalle E, Prado CM, Salvador J, Rolland Y, Santini F, Serlie MJ, Shi H, Sieber CC, Siervo M, Vettor R, Villareal DT, Volkert D, Yu J, Zamboni M, Barazzoni R. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321-335.
    \n    doi: 10.1159\/000521241<\/a>.
    \nEpub 2022 Feb 23.
    \n    PMID: 35196654<\/a>; PMCID: PMC9210010.<\/li>\n
  10. Sheean P, Gonzalez MC, Prado CM, McKeever L, Hall AM, Braunschweig CA. American Society for Parenteral and Enteral Nutrition Clinical Guidelines: The Validity of Body Composition Assessment in Clinical Populations. JPEN J Parenter Enteral Nutr. 2020 Jan;44(1):12-43.
    \n    doi: 10.1002\/jpen.1669<\/a>.
    \nEpub 2019 Jun 19.
    \n    PMID: 31216070<\/a>.<\/li>\n
  11. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W, Muscaritoli M, Pison C, Rutten-van M\u00f6lken M, Slinde F, Steiner MC, Tkacova R, Singh SJ. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014 Dec;44(6):1504-20.
    \n    doi: 10.1183\/09031936.00070914<\/a>.
    \nEpub 2014 Sep 18.
    \n    PMID: 25234804<\/a>.<\/li>\n
  12. McDonald CM, Alvarez JA, Bailey J, Bowser EK, Farnham K, Mangus M, Padula L, Porco K, Rozga M. Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline. J Acad Nutr Diet. 2021 Aug;121(8):1591-1636.e3.
    \n    doi: 10.1016\/j.jand.2020.03.015<\/a>.
    \nEpub 2020 Jun 19.
    \n    PMID: 32565399<\/a>; PMCID: PMC8542104.<\/li>\n
  13. Willig A, Wright L, Galvin TA. Practice Paper of the Academy of Nutrition and Dietetics: Nutrition Intervention and Human Immunodeficiency Virus Infection. J Acad Nutr Diet. 2018 Mar;118(3):486-498.
    \n    doi: 10.1016\/j.jand.2017.12.007<\/a>.
    \nErratum in: J Acad Nutr Diet. 2018 May;118(5):949.
    \n    doi: 10.1016\/j.jand.2018.03.023<\/a>.
    \n    PMID: 29477186<\/a>.<\/li>\n
  14. Guan X, Chen D, Xu Y. Clinical practice guidelines for nutritional assessment and monitoring of adult ICU patients in China. J Intensive Med. 2024 Feb 2;4(2):137-159.
    \n    doi: 10.1016\/j.jointm.2023.12.002<\/a>.
    \n    PMID: 38681796<\/a>; PMCID: PMC11043647.<\/li>\n
  15. Lee Y, Kwon O, Shin CS, Lee SM. Use of bioelectrical impedance analysis for the assessment of nutritional status in critically ill patients. Clin Nutr Res. 2015 Jan;4(1):32-40.
    \n    doi: 10.7762\/cnr.2015.4.1.32<\/a>.
    \nEpub 2015 Jan 23.
    \n    PMID: 25713790<\/a>; PMCID: PMC4337921.<\/li>\n
  16. Prado CM, Gonzalez MC, Norman K, Barazzoni R, Cederholm T, Compher C, Jensen GL, Abe T, Barbosa-Silva TG, Bosy-Westphal A, Carmichael OT, Earthman CP, Evans WJ, Fields DA, Genton L, Hu HH, Kara M, Miles-Chan JL, Mourtzakis M, Muller MJ, Orsso CE, Perkisas S, Sardinha LB, Shepherd JA, Siervo M, Strauss BJ, Yamada Y, Zhu S, Heymsfield SB. Methodological standards for body composition-an expert-endorsed guide for research and clinical applications: levels, models, and terminology. Am J Clin Nutr. 2025 Aug;122(2):384-391.
    \n    doi: 10.1016\/j.ajcnut.2025.05.022<\/a>.
    \nEpub 2025 Jul 17.
    \n    PMID: 40754386<\/a>; PMCID: PMC12405783.<\/li>\n
  17. Prado CM, Gonzalez MC, Norman K, Orsso CE, Barazzoni R, Cederholm T, Compher C, Jensen GL, Abe T, Barbosa-Silva TG, Bennett JP, Carmichael OT, Earthman CP, Evans WJ, Fields DA, Genton L, Hu HH, Kara M, Miles-Chan JL, Mourtzakis M, Paris MT, Perkisas S, Sardinha LB, Shepherd JA, Siervo M, Strauss BJ, Yamada Y, Zhu S, Heymsfield SB. Methodological standards for body composition assessment-an expert-endorsed guide for research and clinical applications: bioimpedance, dual-energy X-ray absorptiometry, computerized tomography, and ultrasound methods. Am J Clin Nutr. 2026 May;123(5):101283.
    \n    doi: 10.1016\/j.ajcnut.2026.101283<\/a>.
    \nEpub 2026 Mar 19.
    \n    PMID: 41864542<\/a>; PMCID: PMC13197919.<\/li>\n
  18. Haute Autorit\u00e9 de Sant\u00e9. Diagnosis of malnutrition in people aged 70 and over. Saint-Denis La Plaine: HAS; 2021.<\/li>\n
  19. Haute Autorit\u00e9 de Sant\u00e9. Diagnosis of malnutrition in children and adults. Saint-Denis La Plaine: HAS; 2019.<\/li>\n
  20. Haute Autorit\u00e9 de Sant\u00e9. Adult obesity: 2nd and 3rd level management. Saint-Denis La Plaine: HAS; 2022.<\/li>\n<\/ol>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

    Over the past two decades, bioelectrical impedance analysis (BIA) has become a mature technology, supported by abundant scientific literature and integrated into numerous clinical practice guidelines. By standardizing its modalities of use, these recommendations strengthen its scientific legitimacy, harmonize clinical practices, and promote its adoption in the assessment of body composition. The first recognitions of […]<\/p>\n","protected":false},"author":8,"featured_media":23313,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"medical-fields":[],"class_list":["post-23307","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en"],"_links":{"self":[{"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/posts\/23307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/comments?post=23307"}],"version-history":[{"count":1,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/posts\/23307\/revisions"}],"predecessor-version":[{"id":23308,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/posts\/23307\/revisions\/23308"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/media\/23313"}],"wp:attachment":[{"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/media?parent=23307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/categories?post=23307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/tags?post=23307"},{"taxonomy":"medical-fields","embeddable":true,"href":"https:\/\/aminogram.com\/en\/wp-json\/wp\/v2\/medical-fields?post=23307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}